The link between human papillomavirus (HPV) infection and different diseases has been
well-established since more than four decades ago [1, 2]. Moreover, high-risk HPV types …

Human papillomavirus (HPV) vaccination of a birth cohort of girls in the 9–13 age range is
recommended as a priority, but decreases in HPV vaccine cost may make catch‐up of a few …

Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines
as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across …

Background. Brazil conducted mass rubella vaccination campaigns to meet disease
elimination goals by 2010. An analysis of rubella vaccination opportunities was conducted to …

In 2008, a national human papillomavirus (HPV) immunization program using a bivalent
vaccine against HPV types 16 and 18 was implemented in Scotland along with a national …

ABSTRACT O ver recent decades, the experi-ence of national immunization programs
demonstrates that im-munization is one of the" best buys" in public health. 1 Rapid …

Since 2006, 115 countries and territories have introduced human papillomavirus (HPV)
vaccination programs. Several efforts have been undertaken to evaluate the impact of HPV …

Background: A vaccine against human papillomavirus (HPV) types 6, 11, 16 and 18 is now
licensed for use in Canada and many other countries. We sought to estimate the number …

Every year in the United States, w15, 000 HPV-associated cancers in women and w7000
HPV-associated cancers in men may be prevented by HPV vaccines. Human papillomavirus …

Up to 2016, low‐and middle‐income countries mostly introduced routine human
papillomavirus (HPV) vaccination for just a single age‐cohort of girls each year. However …